Morrisville, NC · Health Care · Form D filed Sep 2, 2026
Aclarity Genomics, Inc. raised $4.6M
Aclarity Genomics, Inc. is a biotechnology company based in Morrisville, North Carolina. In a Form D filed with the SEC on September 2, 2026, it reported raising $4,625,000 from 8 investors as part of an offering of up to $4,625,000. The first sale in the offering took place on August 17, 2026.
Multiomic solutions made easy. Featuring unmatched speed with whole genome and transcriptome amplification in as little as 30 minutes. try aclarity now Novel Problems Require Novel Solutions Our team…
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
$4.6M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 2, 2026 | $4.6M | $4.6M | 8 |
Lead score
33 out of 100
first raise ever budget to spend website found young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- aclaritygenomics.com
- Amount raised
- $4,625,000
- Offering size
- $4,625,000
- Investors so far
- 8
- First sale
- August 17, 2026
- Securities offered
- Equity, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Morrisville, North Carolina
- Incorporated
- North Carolina, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $4,625,000 | $4,625,000 | 8 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 31, 2026 · Health Care funding in North Carolina · September 2026 funding report
Similar raises
Archaius Inc.
Morrisville, NC · filed Oct 93rd Form D since 2022Still raising
SwabBot, Inc.
Morrisville, NC · filed Aug 18
SwabBot is an automated swabbing robot that protects works, improves accuracy and reduces costs.
First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Gradient Health, Inc.
Durham, NC · filed Oct 7
Access 20M+ de-identified patient journeys via Atlas - Gradient Health's AI healthcare data platform. Fast delivery for AI developers and research teams.
5th Form D since 2022
Toggle Bio
Durham, NC · filed Oct 6
Redefining fluorescent antibodies
First Form D
Dignify Therapeutics, LLC
Research Triangle Park, NC · filed Sep 25
Restoring control of bowel and bladder function Clinical-Stage Company | FDA-Cleared IND | NIH-Funded Phase 1 | >$20M NIH Funding Who We Are Our Approach
2nd Form D since 2014Still raising
Swift Cardiovascular, Inc.
Durham, NC · filed Sep 24First Form DStill raising